CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

What Does the Genetic Testing Landscape Look Like?

What Does the Genetic Testing...

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Scopus BioPharma Makes New Management Appointment Following the Acquisition of Chief Immunotherapy Firm

Scopus BioPharma Makes New Management...

The Impact of AI and ML in Genomics

The Impact of AI and ML in Genomics

Lykan Bioscience Collaborates with Vineti to Take Cell-Based Therapies from the Clinic to the Market

Lykan Bioscience Collaborates with...

Singapore to grow into a global hub of biotechnology

Singapore to grow into a global hub...

US FDA Award VICO with Therapeutics Orphan-Drug Designation for VO659

US FDA Award VICO with Therapeutics...

An Insight into What Genome is

An Insight into What Genome is

What Does the Genetic Testing Landscape Look Like?

What Does the Genetic Testing...

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Scopus BioPharma Makes New Management Appointment Following the Acquisition of Chief Immunotherapy Firm

Scopus BioPharma Makes New Management...

The Impact of AI and ML in Genomics

The Impact of AI and ML in Genomics

Lykan Bioscience Collaborates with Vineti to Take Cell-Based Therapies from the Clinic to the Market

Lykan Bioscience Collaborates with...

Singapore to grow into a global hub of biotechnology

Singapore to grow into a global hub...

US FDA Award VICO with Therapeutics Orphan-Drug Designation for VO659

US FDA Award VICO with Therapeutics...

An Insight into What Genome is

An Insight into What Genome is

Benefits of Genomics-driven Drug Discovery

Life Sciences Review | Monday, August 30, 2021
Tweet

Advances in genotyping technologies have yielded several studies concerning the relationships between the genome and an extensive range of traits.


FREMONT, CA: Genome-wide association studies have found several disease-susceptibility genes. As knowledge of gene-disease connections accumulates, it is increasingly becoming essential to translate this knowledge into clinical practice. This hurdle involves finding effective drug targets and estimating their side effects, which often results in promising clinical trials' failure. Here is a review of recent advances and future perspectives in genetics-led drug discovery, focusing on drug repurposing and the use of multifaceted omics data.


Despite the drastic effort and substantial resources dedicated to biomedical research, only some promising academic discoveries have resulted in new treatments. Such a gap between research and clinical practice is a hurdle for the whole field of biomedical research and is often referred to as the valley of death. One of the reasons for this gap is the biological differences between humans and other model organisms.


Validation in other organisms, like mice, does not necessarily mean that the outcomes will be replicated in humans. Investigating the effect of human genetic variation on phenotypes can offer insight into pathophysiology in the human body, which will result in the discovery of true drug targets.


One effective method for improving clinical practice is drug repurposing. Drug repurposing is a method for finding new indications for existing approved drugs or drugs in clinical trials. If the drug's safety has been confirmed in early-stage clinical trials for its original intention, repurposing existing drugs needs less cost for testing the safety than developing and deploying novel drugs. The data on disease-susceptibility genes for drug repurposing has been exploited. The use of existing drug classification systems is a promising method to systematically assess gene–drug associations for several diseases.


Given the requirement for novel drug development, prioritizing genes as therapeutic targets is a decisive step. These leading studies demonstrate that insight into disease-susceptibility genes is a potential resource for more efficient drug discovery. The coupling of other biological data is also vital to drug discovery.


See Also :Towards a New World Order


Weekly Brief

loading
Top 10 Genomics Solution Companies in Europe - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/benefits-of-genomicsdriven-drug-discovery-nwid-350.html